DPYD and cutaneous melanoma: A cancer systems biology analysis of skin cutaneous melanoma broughtforward a new master regulator and diagnostic target in cancer metabolism.Somatic mutations of DPYD have the ability to reconfigure and activatepyrimidine metabolism promoting rapid cellular proliferation and metastaticprogression [44].